The microbiome therapeutics landscape shows remarkable growth with over 140 companies actively developing 180+ pipeline drugs, spanning various disease areas and therapeutic approaches.
At CES 2025, Tuya Smart showcased AI-driven innovations and strategic partnerships, while other companies like Mativ Holdings and Vision Marine Technologies announced significant advancements in their respective fields. The event also highlighted developments in healthcare, biotechnology, and the energy sector, showcasing the latest in technology and strategic collaborations.